Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With HIV
Steven Grinspoon(Massachusetts General Hospital), Markella V. Zanni(Harvard University), Heather J. Ribaudo(Cancer Research And Biostatistics), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Sarah M Chu(Harvard University), Sophia Zhao(Austin Health), Roger Bedimo(The University of Texas Southwestern Medical Center), Sara E. Looby(Cancer Research And Biostatistics), Pamela S. Douglas(Duke University), Juan Carlos López-Bernaldo de Quirós(Instituto de Salud Carlos III), Michael T. Lu(Cancer Research And Biostatistics), Triin Umbleja(Harvard University), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Gerald S. Bloomfield, Samir K. Gupta(Indiana University School of Medicine), Estebán Martínez(Instituto de Salud Carlos III), Marissa R Diggs(Harvard University), Judith S. Currier(University of California, Los Angeles), Kathleen V. Fitch(Harvard University), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Olabimpe Asupoto(Tufts Medical Center), Daniel E. Nixon(Virginia Commonwealth University), Maya Watanabe(Cancer Research And Biostatistics), Kristine M. Erlandson(University of Colorado Denver)
Cited by 7
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k